Sigma Healthcare (ASX:SIG) Short-Term Debt: A$201 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:SIG Sigma Healthcare Ltd ASX:SIG
58 GF Score
Price A$2.94
GF Value A$0.37
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare Short-Term Debt?

Sigma Healthcare ASX:SIG +0.34% 58 Short-Term Debt is A$201 Mil as of Dec. 2025. GuruFocus rates ASX:SIG with a GF Score™ of 58/100 and a GF Value™ of A$0.37 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Sigma Healthcare's Short-Term Debt for the quarter that ended in Dec. 2025 was A$201 Mil.

Sigma Healthcare's quarterly Short-Term Debt declined from Jul. 2024 (A$13 Mil) to Jan. 2025 (A$0 Mil) but then increased from Jan. 2025 (A$0 Mil) to Dec. 2025 (A$201 Mil).

Sigma Healthcare's annual Short-Term Debt declined from Jan. 2023 (A$4 Mil) to Jan. 2024 (A$0 Mil) but then stayed the same from Jan. 2024 (A$0 Mil) to Jan. 2025 (A$0 Mil).

Sigma Healthcare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Sigma Healthcare Short-Term Debt Related Terms

Sigma Healthcare Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare Short-Term Debt Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.38 15.38 3.68 0.00 0.00

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.62 0.00 13.33 0.00 200.74
ASX:SIG
58GF Score
Sigma Healthcare Ltd ASX:SIG
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of A$201 Mil mean?
Sigma Healthcare (ASX:SIG) has a Short-Term Debt of A$201 Mil as of Dec. 2025.
Is Sigma Healthcare's Short-Term Debt too high?
Sigma Healthcare's current Short-Term Debt is A$201 Mil. Overall, Sigma Healthcare has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's Short-Term Debt compare to MCK and CAH?
Sigma Healthcare's Short-Term Debt of A$201 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Medical Distribution company?
A good Short-Term Debt depends on the Medical Distribution industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Sigma Healthcare's current Short-Term Debt is A$201 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sigma Healthcare (ASX:SIG) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.37, compared to a current price of A$2.94 — trading 694.6% above its estimated fair value. The current Short-Term Debt is A$201 Mil. Sigma Healthcare's overall GF Score™ is 58/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Sigma Healthcare (ASX:SIG), the current Short-Term Debt is A$201 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (ASX:SIG) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of A$2.94 is trading 694.6% above its estimated GF Value™ of A$0.37. GuruFocus considers Sigma Healthcare to be Significantly Overvalued.

Key valuation signals for ASX:SIG:

  • Short-Term Debt: A$201 Mil
  • GF Value™: A$0.37 vs. price of A$2.94 (694.6% above fair value)
  • GF Score™: 58/100 with 8 warning signs

No single metric tells the full story. See the ASX:SIG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sigma Healthcare Business Description

Other Exchanges SIGGF:USA
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
58GF Score

Get the complete analysis for ASX:SIG

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.94
Price
A$0.37
GF Value